## NotesToFinancialStatementsCompensationAndEmployeeBenefitPlansTextBlockTables

**Year Ended**

|  | Sep 27, 2014 |
| --- | --- |
| **      Restricted Stock Activity** | A summary of the Company’s RSU activity and
related information for 2014, 2013 and 2012, is as follows:

                                                  Weighted-Average  
                                                        Grant Date  
                                                              Fair  
                                                   Value Per Share  
 ────────────────────────────────────────────────────────────────────
  Balance at September 24, 2011      101,122                $33.07  
  RSUs granted                        54,597                $61.62  
  RSUs vested                        (44,137                $29.32  
  RSUs cancelled                      (6,545                $36.57  
  Balance at September 29, 2012      105,037                $49.27  
  RSUs granted                        39,415                $78.23  
  RSUs vested                        (42,291                $45.96  
  RSUs cancelled                      (8,877                $57.31  
  Balance at September 28, 2013       93,284                $62.24  
  RSUs granted                        59,269                $74.54  
  RSUs vested                        (43,111                $57.29  
  RSUs cancelled                      (5,620                $68.47  
  Balance at September 27, 2014      103,822                $70.98
 |
| **      Summary of Share-Based Compensation Expense** | The following table shows a summary of the
share-based compensation expense included in the Consolidated
Statements of Operations for 2014, 2013 and 2012 (in millions):

                                              2014                 2013         
2012             
 ───────────────────────────────────────────────────────────────────────────────
──────────────────────────
  Cost of sales                               $           450      $           
350      $           265  
  Research and development                              1,216                  
917                  668  
  Selling, general and administrative                   1,197                  
986                  807  
  Total share-based compensation expense      $         2,863      $         
2,253      $         1,740
 |